My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Eli Lilly And Co

Recent news which mentions Eli Lilly And Co

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
Tags Zealand Pharma A/S Augmedix Inc Healthy Returns
From CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
Tags Health & Science Science Biotech and Pharmaceuticals
From CNBC.com News
Swiss pharma giant Roche to accelerate Wegovy rival drugs after positive trial data
Tags Business Business News Roche Holding AG
From CNBC.com News
European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai
Tags Business US: News Companies
From CNBC.com News
Viking Therapeutics stock jumps 16% after drugmaker moves weight loss injection to late-stage trial
Tags Business News Viking Therapeutics Inc Breaking News: Business
From CNBC.com News
Jim Cramer supports megacaps for the long term, even as Wall Street continues to sell
Tags Meta Platforms Inc Apple Inc Alphabet Inc
From CNBC.com News
CNBC Daily Open: Rising geopolitical risk
Tags Microsoft Corp Inflation United Airlines Holdings Inc
From CNBC.com News
CNBC Daily Open: Rising geopolitical risk
Tags Air travel Asia Markets Meta Platforms Inc
From CNBC.com News
Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche
Tags Eli Lilly and Co Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
Tags Biotech and Pharmaceuticals Pfizer Inc Health & Science
From CNBC.com News
Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
Tags Novo Nordisk A/S Eli Lilly and Co Health care industry
From CNBC.com News
Pfizer moves forward with once-daily version of weight loss pill after setbacks
Tags Pharmaceuticals Pfizer Inc Health care industry
From CNBC.com News
Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong'
Tags Stock markets Business News Mad Money
From CNBC.com News
Jim Cramer reviews 8 companies that could top $1 trillion in market cap
Tags stocks Alphabet Inc Apple Inc
From CNBC.com News
FTC to sue drug middlemen over prices of medications including insulin
Tags UnitedHealth Group Inc Business News Politics
From CNBC.com News
Companies besides tech can reach megacap status, Jim Cramer says
Tags Stock Picks Eli Lilly and Co Microsoft Corp
From CNBC.com News
This ETF is trying to satisfy appetites for weight loss stocks
Tags Health care costs Mondelez International Inc Stock markets
From CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
Tags Oracle Corp Gilead Sciences Inc Cigna Corp
From CNBC.com News
CNBC Daily Open: Tesla soars, S&P closes above 5,500
Tags World Markets Electric vehicles Daily Open
From CNBC.com News
CNBC Daily Open: Tesla soars, S&P closes above 5,500
Tags Technology Oil and Gas Tesla Inc
From CNBC.com News
FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.
Tags Biotechnology Health care industry Pharmaceuticals
From CNBC.com News
Watch now: ETF Edge on reshoring trends, weight loss drugs and more
Tags Amgen Inc Investment strategy US: News
From CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
Tags Zealand Pharma A/S Healthy Returns Viking Therapeutics Inc
From CNBC.com News
Jim Cramer's top picks for pet-centric stocks
Tags U/S/ Markets Chewy Inc Elanco Animal Health Inc
From CNBC.com News
Novo Nordisk's Wegovy weight loss drug approved in China
Tags Asia News US Top News and Analysis US: News
From CNBC.com News
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
Tags Health care industry Biotechnology Novo Nordisk A/S
From CNBC.com News
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year
Tags Business US: News Companies
From CNBC.com News
Weight loss drug contender Zealand Pharma jumps 23% on trial results
Tags Eli Lilly and Co Novo Nordisk A/S Europe Markets
From CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
Tags Healthy Returns Social issues Labor economy
From CNBC.com News
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
Tags Health care industry Novo Nordisk A/S Biotechnology
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.